B-type natriuretic peptide and renal disease

Area of Science:

• Cardiology
• Nephrology
• Biomarkers

Background:

• B-type natriuretic peptide (BNP) is a cardiac neurohormone impacting renal function.
• BNP and renal function are prognostic indicators in congestive heart failure (CHF).
• The interplay between BNP, renal function, and CHF diagnosis requires further elucidation.

Purpose of the Study:

• To investigate the relationship between BNP, estimated glomerular filtration rate (eGFR), and CHF diagnosis.
• To determine the diagnostic utility of BNP in patients with impaired renal function.
• To explore the role of N-terminal proBNP (NT-proBNP) in relation to renal function.

Main Methods:

• Correlation analysis between BNP and eGFR.
• Receiver operating characteristic (ROC) curve analysis to assess diagnostic performance at specific eGFR thresholds.
• Comparison of BNP and NT-proBNP correlations with eGFR.

Main Results:

• A moderate negative correlation (r = -0.20) was observed between BNP and eGFR.
• An elevated BNP cutpoint of approximately 200 pg/ml demonstrated diagnostic value for CHF when eGFR < 60 ml/min/1.73 m2 (AUC = 0.81).
• NT-proBNP showed a stronger negative correlation with eGFR (r = -0.60) and was influenced by age-related renal function decline.

Conclusions:

• BNP is a valuable diagnostic tool for CHF, particularly in patients with reduced kidney function.
• NT-proBNP exhibits a closer relationship with renal function than BNP.
• BNP's role as a heart-kidney signaling molecule suggests its utility in managing combined heart and renal failure.